Acorda Therapeutics

ACOR

16.25

+0.70

+4.5%

Stock Price
Open: 15.50
Prev. Close: 15.55
Low/Hi: 15.50 - 16.35
52-Week: 15.30 - 33.00
Volumes
Equity: 128,879
90-Day Avg: 1,033,092
Option: 1
90-Day Avg: 1,637
Volatility
Today: 71.1
20-Day: 56.1
52-Week: 49.8
30-Day IV: 45.6 +1.3
IV Rank: 0.16 (Subdued)
Fundamental
Div. Yield: 0.0%
Earnings: 28-Jul (Est.)
P/E Ratio:
Market Cap: 727.1 M
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ACOR Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 31-Dec-2016 30-Sep-2016 30-Jun-2016 31-Mar-2016
Cash and Cash Equivalents 158,537 127,940 137,400 431,414
Short Term Investments 0 0 0 0
Investments - - - -
Accounts Receivable 52,239 48,575 45,886 41,623
Inventory 43,135 40,935 55,553 39,667
Loans - - - -
Prepaid Expenses 12,907 15,639 18,709 14,312
Net Property Plant and Equipment 34,310 35,777 36,754 38,027
Other Current Assets 5,839 4,863 5,616 17,265
Current Assets 272,657 237,952 263,164 544,281
Goodwill and Intangibles 1,022,841 1,033,444 1,036,028 614,127
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 1,342,335 1,318,368 1,346,539 1,211,694
Short Term Debt 0 0 0 0
Other Non-Current Assets 12,527 11,195 10,593 15,259
Accounts Payable 26,933 18,557 29,554 21,355
Accrued Liabilities and Other Payables 104,890 89,374 96,388 73,475
Long Term Debt 324,030 297,111 294,854 292,624
Other Liabilities - - - -
Current Portion of Long Term Debt 7,021 1,134 1,126 1,117
Total Liabilities 678,124 651,602 664,997 527,682
Other Current Liabilities 9,057 9,057 9,057 9,057
Accumulated Other Comprehensive Income -12,901 -3,615 -4,711 0
Preferred Stock 0 0 0 0
Current Liabilities 147,901 118,122 136,125 105,004
Common Stock 46 46 46 46
Other Non-Current Liabilities 206,193 236,369 234,018 130,054
Additional Paid-In Capital 921,365 911,540 904,784 894,167
Treasury Stock -329 -329 -329 -329
Other Equity 0 0 9,904 0
Retained Earnings -243,970 -240,876 -228,152 -209,872
Total Equity 664,211 666,766 681,542 684,012
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 158,537 153,204 182,170 48,037
Short Term Investments 0 200,101 125,448 225,891
Investments - - - -
Accounts Receivable 52,239 31,466 32,211 30,784
Inventory 43,135 36,476 26,837 26,172
Loans - - - -
Prepaid Expenses 12,907 16,079 15,523 8,398
Net Property Plant and Equipment 34,310 40,204 46,090 16,525
Other Current Assets 5,839 13,991 26,949 28,051
Current Assets 272,657 451,317 409,138 367,333
Goodwill and Intangibles 1,022,841 614,492 615,774 17,459
Long Term Investments 0 0 0 93,299
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 1,342,335 1,116,343 1,080,679 607,127
Short Term Debt 0 0 0 0
Other Non-Current Assets 12,527 10,330 9,677 112,511
Accounts Payable 26,933 14,233 17,751 15,922
Accrued Liabilities and Other Payables 104,890 66,133 56,118 37,569
Long Term Debt 324,030 296,576 289,883 3,721
Other Liabilities - - - -
Current Portion of Long Term Debt 7,021 1,169 2,037 2,005
Total Liabilities 678,124 513,318 540,424 166,774
Other Current Liabilities 9,057 9,057 38,477 41,147
Accumulated Other Comprehensive Income -12,901 -119 -74 37
Preferred Stock 0 0 0 0
Current Liabilities 147,901 90,592 114,383 96,643
Common Stock 46 43 42 41
Other Non-Current Liabilities 206,193 126,150 136,158 66,410
Additional Paid-In Capital 921,365 812,782 761,026 678,686
Treasury Stock -329 -329 -329 -329
Other Equity 0 0 0 0
Retained Earnings -243,970 -209,352 -220,410 -238,082
Total Equity 664,211 603,025 540,255 440,353